Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene

[1]  J. Ihle,et al.  Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand , 1993, Molecular and cellular biology.

[2]  James M. Roberts,et al.  Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. , 1993, Science.

[3]  A. Ullrich,et al.  Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. , 1993, Science.

[4]  T. Pawson,et al.  SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. , 1993, Science.

[5]  Z. Zhao,et al.  Purification and characterization of a protein tyrosine phosphatase containing SH2 domains. , 1993, The Journal of biological chemistry.

[6]  Ornella Parolini,et al.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.

[7]  J. Bolen,et al.  The Src family of tyrosine protein kinases in hemopoietic signal transduction , 1992, Stem cells.

[8]  R. Perlmutter,et al.  Regulation of lymphocyte function by protein phosphorylation. , 1993, Annual review of immunology.

[9]  B. Neel,et al.  Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Angeletti,et al.  Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1. , 1992, The Journal of biological chemistry.

[11]  N. Copeland,et al.  Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6. , 1992, Genomics.

[12]  D. Beier,et al.  Mapping genes in the mouse using single-strand conformation polymorphism analysis of recombinant inbred strains and interspecific crosses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Eddy,et al.  Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6). , 1992, Genomics.

[14]  E S Lander,et al.  A genetic map of the mouse suitable for typing intraspecific crosses. , 1992, Genetics.

[15]  M. Thomas,et al.  Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences , 1992, Molecular and cellular biology.

[16]  H. Gaskins,et al.  The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Cleveland,et al.  Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13 , 1992, Molecular and cellular biology.

[18]  B. Neel,et al.  Isolation of a src homology 2-containing tyrosine phosphatase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Hill,et al.  Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. , 1992, Cancer research.

[20]  J. Spivak,et al.  Protein kinases and phosphatases are involved in erythropoietin-mediated signal transduction. , 1992, Experimental hematology.

[21]  A. Kantor.  The development and repertoire of B-1 cells (CD5 B cells). , 1991, Immunology today.

[22]  L. Shultz.  Hematopoiesis and models of immunodeficiency. , 1991, Seminars in immunology.

[23]  J. Cleveland,et al.  Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification. , 1991, Blood.

[24]  J. Ihle,et al.  Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis , 1991, Molecular and cellular biology.

[25]  P. Chrétien,et al.  A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases , 1991, Nature.

[26]  J. Dasch,et al.  Suppressive effects of monocytic cells and transforming growth factor-beta on natural killer cell differentiation in autoimmune viable motheaten mutant mice. , 1991, Journal of immunology.

[27]  L. Shultz.  Immunological mutants of the mouse. , 1991, The American journal of anatomy.

[28]  L. Shultz,et al.  Synthesis of abnormal immunoglobulins by hybridomas from autoimmune "viable motheaten" mutant mice , 1991, The Journal of cell biology.

[29]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[30]  F. Behm,et al.  New recurring chromosomal translocations in childhood acute lymphoblastic leukemia. , 1991, Blood.

[31]  L. Shultz,et al.  Phorbol ester responsiveness of murine Ly‐1‐lineage B cells from normal and viable motheaten mutant mice , 1991, European journal of immunology.

[32]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[33]  C. Bona,et al.  Germline V genes encode viable motheaten mouse autoantibodies against thymocytes and red blood cells. , 1990, Journal of immunology.

[34]  J. Massagué,et al.  Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.

[35]  A. Freitas,et al.  VH gene family repertoires of “viable motheaten” (mev) mice , 1990, European journal of immunology.

[36]  T. Roberts,et al.  Oncogenes, growth factors, and signal transduction. , 1989, The New England journal of medicine.

[37]  L. Shultz,et al.  Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). , 1989, Experimental hematology.

[38]  L. Shultz,et al.  Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice. , 1988, Journal of immunology.

[39]  C. Bona,et al.  Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice , 1988, The Journal of experimental medicine.

[40]  L. Shultz.  Pleiotropic effects of deleterious alleles at the "motheaten" locus. , 1988, Current topics in microbiology and immunology.

[41]  F. Behm,et al.  tdic(9;12): A nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: A pediatric oncology group study , 1987 .

[42]  D. Greiner,et al.  Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. III. Normal mouse bone marrow cells enable mev/mev prothymocytes to generate thymocytes after intravenous transfer , 1987, The Journal of experimental medicine.

[43]  D. Greiner,et al.  Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro. , 1987, Journal of immunology.

[44]  L. Shultz,et al.  Development of plasmacytoid cells with Russell bodies in autoimmune "viable motheaten" mice. , 1987, The American journal of pathology.

[45]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[46]  L. Shultz,et al.  Genetically determined murine models of immunodeficiency. , 1987, Annual review of immunology.

[47]  L. Herzenberg,et al.  The LY‐1B Cell Lineage , 1986 .

[48]  S. Raimondi,et al.  Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia , 1986 .

[49]  R. Hardy,et al.  Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. , 1986, Science.

[50]  Charles J. Sherr,et al.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.

[51]  J. H. Chen,et al.  The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity. , 1985, Science.

[52]  J. Armstrong,et al.  Retroviral infection of accessory cells and the immunological paradox in AIDS. , 1985, Immunology today.

[53]  D. George,et al.  Regional mapping of cKi-ras proto-oncogene on mouse chromosome 6 by in situ hybridization. , 1985, Cytogenetics and cell genetics.

[54]  L. Shultz,et al.  "Viable motheaten," a new allele at the motheaten locus. I. Pathology. , 1984, The American journal of pathology.

[55]  L. Shultz,et al.  Hematopoietic stem cell function in motheaten mice. , 1983, Experimental hematology.

[56]  D. Hanahan.  Studies on transformation of Escherichia coli with plasmids. , 1983, Journal of molecular biology.

[57]  H. Morse,et al.  Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes. , 1979, Journal of immunology.

[58]  E. Unanue,et al.  The mouse mutant "motheaten". I. Development of lymphocyte populations. , 1978, Journal of immunology.

[59]  B. Mansa,et al.  A study of Russell bodies in human monoclonal plasma cells by means of immunofluorescence and electron microscopy. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[60]  L. Shultz,et al.  Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. , 1976, Journal of immunology.

[61]  Otto Hf,et al.  Plasma cell alterations in ulcerative colitis. An electron microscopic study. , 1976 .

[62]  L. Shultz,et al.  Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. , 1975, The Journal of heredity.

[63]  D. Miller,et al.  Familial reticuloendotheliosis: concurrence of disease in five siblings. , 1966, Pediatrics.